date
stringlengths 23
23
| title
stringlengths 1
512
⌀ | stock
stringlengths 1
6
⌀ |
|---|---|---|
2018-05-15 00:00:00 UTC
|
25 Stocks Moving In Tuesday's Pre-Market Session
|
A
|
2018-05-14 00:00:00 UTC
|
10 Stocks Moving In Monday's After-Hours Session
|
A
|
2018-05-14 00:00:00 UTC
|
Agilent Technologies Shares Down 6.5% After Hours Following Mixed Q2 Results; Co. Reaffirmed Downbeat Q3 And FY18 Guidance Estimates
|
A
|
2018-05-14 00:00:00 UTC
|
Agilent Technologies Reaffirms FY2018 EPS ~$2.65 vs $2.70 Est., Core Sales Growth 5.5%
|
A
|
2018-05-14 00:00:00 UTC
|
Agilent Technologies Sees Q3 EPS $0.61-0.63 vs $0.65 Est; Sees Sales $1.19B-1.21B vs $1.21B Est
|
A
|
2018-05-14 00:00:00 UTC
|
Agilent Technologies Q2 EPS $0.65 Beats $0.64 Estimate, Sales $1.206B Miss $1.21B Estimate
|
A
|
2018-05-14 00:00:00 UTC
|
The Week Ahead: Coindesk Conference, Walmart And Retailers Close Out Earnings Season
|
A
|
2018-05-14 00:00:00 UTC
|
7 Stocks To Watch For May 14, 2018
|
A
|
2018-05-14 00:00:00 UTC
|
Earnings Scheduled For May 14, 2018
|
A
|
2018-05-02 00:00:00 UTC
|
Agilent Reports Purchase Of Genohm, No Terms Disclosed
|
A
|
2018-04-18 00:00:00 UTC
|
Agilent Technologies Files Second Civil Action Against Changzhou Pannatek to 'Protect Intellectual Property'
|
A
|
2018-04-11 00:00:00 UTC
|
Morgan Stanley Maintains Overweight on Agilent Technologies, Lowers Price Target to $91.00
|
A
|
2018-04-03 00:00:00 UTC
|
UPDATE: Alnylam, Agilent Deal Has Initial Term Of 5 Years, With Automatic Renewal Terms OF 2 Years Absent Earlier Termination, No Further Terms Disclosed
|
A
|
2018-04-03 00:00:00 UTC
|
Alnylam Pharma 8-K Shows Co. Entered Manufacturing Services Deal With Agilent For Providing Of Commercial Supply Of Patisiran
|
A
|
2018-04-03 00:00:00 UTC
|
Agilent Technologies Signs Agreement To Acquire Lasergen For $105M
|
A
|
2018-03-07 00:00:00 UTC
|
Agilent Technologies to Acquire Advanced Analytical Technologies for $250M in Cash
|
A
|
2018-02-15 00:00:00 UTC
|
Bank Of America Out Positive On Agilent, Raises Price Target From $80 To $83 As Frim Says Core Business Continues To Do Well, Led By C&E Strength And Pharma; Remains A Focus Stock For Bank of America
|
A
|
2018-02-15 00:00:00 UTC
|
JP Morgan Maintains Overweight on Agilent Technologies Inc, Raises price target to $80.00
|
A
|
2018-02-14 00:00:00 UTC
|
Agilent Sees Q2 Adj. EPS $0.61-$0.63 vs $0.64 Est., Sales $1.2B-$1.22B vs $1.17B Est.; FY18 Adj. EPS $2.62-$2.68 vs $2.59 Est., Sales $4.885B-$4.905B vs $5.04B Est.
|
A
|
2018-02-14 00:00:00 UTC
|
Agilent Reports Q1 Adj. EPS $0.66 vs $0.58 Est., Sales $1.21B vs $1.16B Est.
|
A
|
2018-02-14 00:00:00 UTC
|
Earnings Scheduled For February 14, 2018
|
A
|
2018-02-13 00:00:00 UTC
|
Phillips 66 Says it Has Agreed to Repurchase 35M Shares of Phillips 66 Common Stock from Wholly-owned Subsidiary of Berkshire Hathaway
|
A
|
2018-01-29 00:00:00 UTC
|
Agilent Reports Scientific Partnership with the University of Southern California
|
A
|
2018-01-23 00:00:00 UTC
|
The 10 Most Expensive Stocks In The S&P 500
|
A
|
2018-01-09 00:00:00 UTC
|
JP Morgan Healthcare Conference Continues Today, Presenters Include: Bluebird Bio, Agilent, Insulet, Cigna, DexCom, Eli Lilly, LifePoint, Acadia, Alkermes, Juno Therapeutics
|
A
|
2018-01-09 00:00:00 UTC
|
Agilent Reports Purchase Of Luxcel Biosciences, No Terms Disclosed
|
A
|
2018-01-04 00:00:00 UTC
|
Evercore ISI Group Initiates Coverage On Agilent Technologies with Outperform Rating, Announces $75.00 Price Target
|
A
|
2018-01-04 00:00:00 UTC
|
Goldman Sachs Healthcare CEOs Unscripted Conference Taking Place Today; Presenters Include Agilent, Bluebird Bio, Boston Scientific, Alexion, Eli Lilly, and Alnylam
|
A
|
2017-12-08 00:00:00 UTC
|
Aquinox Pharmaceuticals Announces FDA Panel Voted 15 to 0 That Patients With Interstitial Cystitis and Patients With Bladder Pain Syndrome Should Be Combined in Clinical Trials
|
A
|
2017-11-21 00:00:00 UTC
|
Deutsche Bank Says Agilent Can Be The Next 'Compounder' In The Life Science Tools & Diagnostics Space Based On Product Cycles, Margin Expansion Opportunities, and Balanced End Market Exposures
|
A
|
2017-11-21 00:00:00 UTC
|
33 Stocks Moving In Tuesday's Pre-Market Session
|
A
|
2017-11-21 00:00:00 UTC
|
14 Stocks To Watch For November 21, 2017
|
A
|
2017-11-20 00:00:00 UTC
|
7 Stock's Moving In Monday's After-Hours Session
|
A
|
2017-11-20 00:00:00 UTC
|
Agilent Sees Q1 Adj. EPS $0.55-$0.57 vs $0.60 Est., Sales $1.145B-$1.165B vs $1.15B Est.
|
A
|
2017-11-20 00:00:00 UTC
|
Agilent Sees FY18 Adj. EPS $2.50-$2.56 vs $2.59 Est., Sales $4.72B-$4.74B vs $4.73B Est.
|
A
|
2017-11-20 00:00:00 UTC
|
Agilent Reports Q4 Adj. EPS $0.67 vs $0.62 Est., Sales $1.19B vs $1.17B Est.
|
A
|
2017-11-20 00:00:00 UTC
|
7 Stocks To Watch For November 20, 2017
|
A
|
2017-11-20 00:00:00 UTC
|
Earnings Scheduled For November 20, 2017
|
A
|
2017-11-15 00:00:00 UTC
|
Agilent Raises Qtr. Dividend From $0.13/Share To $0.149/Share
|
A
|
2017-11-14 00:00:00 UTC
|
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $88.00
|
A
|
2017-09-22 00:00:00 UTC
|
Agilent Technologies Receives FDA Approval For Use Of Dako PD-L1 For Treatment With Merck's KEYTRUDA In Gastric or Gastroesophageal Junction Cancer
|
A
|
2017-09-19 00:00:00 UTC
|
Agilent Reports Dako PD-L1 IHC 28-8 PharmDx Approved For 2 New Indications: Urothelial Carcinoma, Squamous Cell Carcinoma Of Head And Neck
|
A
|
2017-09-13 00:00:00 UTC
|
Agilent Reports FDA Approval Of GenetiSure Dx Postnatal Assay
|
A
|
2017-08-23 00:00:00 UTC
|
Agilent Files Civil Lawsuit against Shanghai Echrom Electronic Technology Co.
|
A
|
2017-08-16 00:00:00 UTC
|
12 Biggest Mid-Day Gainers For Wednesday
|
A
|
2017-08-16 00:00:00 UTC
|
3 Things Deutsche Bank Likes About Agilent's Q3, And One Thing To Be Cautious Of
|
A
|
2017-08-16 00:00:00 UTC
|
5 Things That Stood Out In Another Beat And Raise Quarter From Agilent
|
A
|
2017-08-16 00:00:00 UTC
|
20 Stocks Moving In Wednesday's Pre-Market Session
|
A
|
2017-08-16 00:00:00 UTC
|
A Peek Into The Markets: U.S. Stock Futures Rise; All Eyes On Fed Minutes
|
A
|
2017-08-16 00:00:00 UTC
|
8 Stocks To Watch For August 16, 2017
|
A
|
2017-08-15 00:00:00 UTC
|
Agilent Sees Q4 Adj. EPS $0.60-$0.62 vs $0.60 Est., Sales $1.15B-$1.17B vs $1.15B Est.; FY17 Adj. EPS $2.29-$2.31 vs $2.23 Est., Sales $4.435B-$4.455B vs $4.41B Est.
|
A
|
2017-08-15 00:00:00 UTC
|
Agilent Technologies Reports Q3 Adj. EPS $0.59 vs $0.52 Est., Sales $1.11B vs $1.09B Est.
|
A
|
2017-08-15 00:00:00 UTC
|
10 Stocks To Watch For August 15, 2017
|
A
|
2017-08-15 00:00:00 UTC
|
Earnings Scheduled For August 15, 2017
|
A
|
2017-07-24 00:00:00 UTC
|
Agilent Acquires Powerful Next Gen Sequencing IP Portfolio, No Terms Disclosed
|
A
|
2017-07-13 00:00:00 UTC
|
Wells Fargo Upgrades Agilent Technologies to Outperform
|
A
|
2017-07-07 00:00:00 UTC
|
Agilent Reports Purchase Of Cobalt Light Systems For £40M In Cash
|
A
|
2017-06-28 00:00:00 UTC
|
Unisys ClearPath Software Selected by Malaysia's ANGKASA
|
A
|
2017-06-23 00:00:00 UTC
|
Why Agilent Technologies (A) Stock Might be a Great Pick
|
A
|
2017-06-23 00:00:00 UTC
|
Why Agilent Technologies (A) Stock Might be a Great Pick
|
A
|
2017-06-19 00:00:00 UTC
|
All Mixed Up
|
A
|
2017-06-14 00:00:00 UTC
|
Goldman Sachs Global Healthcare Conference Continues Today, Presenters Include: Agilent, Sage Therapeutics, and GW Pharmaceuticals
|
A
|
2017-06-08 00:00:00 UTC
|
Unisys Launches FamilyNow for Aiding Social Service Agencies
|
A
|
2017-06-06 00:00:00 UTC
|
Jefferies Health Care Conference Begins Today, Presenters Include: Agilent Technologies, Civitas Solutions, Aeri Pharmaceuticals, Alkermes, Alnylam Pharmaceuticals, Heron Therapeutics
|
A
|
2017-06-02 00:00:00 UTC
|
Agilent Reports Deal with Agendia for Molecular Cancer Diagnostics
|
A
|
2017-05-30 00:00:00 UTC
|
Agilent Spikes to High of $60.40 on Volume
|
A
|
2017-05-23 00:00:00 UTC
|
15 Biggest Mid-Day Gainers For Tuesday
|
A
|
2017-05-23 00:00:00 UTC
|
Agilent Technologies Sharply Higher After Q2 Beat
|
A
|
2017-05-23 00:00:00 UTC
|
5 Biggest Price Target Changes For Tuesday
|
A
|
2017-05-23 00:00:00 UTC
|
20 Stocks Moving In Tuesday's Pre-Market Session
|
A
|
2017-05-23 00:00:00 UTC
|
A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Reports
|
A
|
2017-05-23 00:00:00 UTC
|
8 Stocks To Watch For May 23, 2017
|
A
|
2017-05-22 00:00:00 UTC
|
UPDATE: Agilent Raises FY17 Adj. EPS Outlook to $2.15-$2.21 vs $2.16 Est., Sales to $4.36B-$4.38B vs $4.35B Est.
|
A
|
2017-05-22 00:00:00 UTC
|
Agilent Sees Q3 Adj. EPS $0.49-$0.51 vs $0.53 Est., Sales $1.06B-$1.08B vs $1.08B Est.
|
A
|
2017-05-22 00:00:00 UTC
|
Agilent Raises FY Outlook
|
A
|
2017-05-22 00:00:00 UTC
|
Agilent Reports Q2 Adj. EPS $0.58 vs $0.48 Est., Sales $1.1B vs $1.05B Est.
|
A
|
2017-05-22 00:00:00 UTC
|
5 Stocks To Watch For May 22, 2017
|
A
|
2017-05-22 00:00:00 UTC
|
Earnings Scheduled For May 22, 2017
|
A
|
2017-03-31 00:00:00 UTC
|
7 Biggest Price Target Changes For Friday
|
A
|
2017-03-15 00:00:00 UTC
|
Agilent Names Koh Boon Hwee Chair
|
A
|
2017-03-15 00:00:00 UTC
|
18 Biggest Mid-Day Gainers For Wednesday
|
A
|
2017-03-15 00:00:00 UTC
|
Benzinga's Top Upgrades, Downgrades For March 15, 2017
|
A
|
2017-03-15 00:00:00 UTC
|
Morgan Stanley Upgrades Agilent Technologies To Overweight
|
A
|
2017-03-13 00:00:00 UTC
|
The Technician's Playbook: 11 Sector Pair Trades
|
A
|
2017-03-08 00:00:00 UTC
|
Cowen Annual Healthcare Conference Concludes Today; Presenters Include Agilent Tech, Incyte, GW Pharma, Teva Pharma, NantKwest, Seattle Genetics, And Celgene
|
A
|
2017-02-15 00:00:00 UTC
|
5 Biggest Price Target Changes For Wednesday
|
A
|
2017-02-14 00:00:00 UTC
|
Agilent Raises FY17 Outlook
|
A
|
2017-02-14 00:00:00 UTC
|
Agilent Reports Q1 Adj. EPS $0.53 vs $0.49 Est., Sales $1.07B vs $1.05B Est.
|
A
|
2017-02-14 00:00:00 UTC
|
Earnings Scheduled For February 14, 2017
|
A
|
2017-01-18 00:00:00 UTC
|
Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector
|
A
|
2017-01-11 00:00:00 UTC
|
Hearing Thermo Fisher In Talks To Buy Agilent
|
A
|
2017-01-04 00:00:00 UTC
|
7 Biggest Price Target Changes For Wednesday
|
A
|
2017-01-04 00:00:00 UTC
|
Benzinga's Top Upgrades, Downgrades For January 4, 2017
|
A
|
2017-01-04 00:00:00 UTC
|
Barclays Upgrades Agilent Technologies to Overweight, Raises Target to $51.00
|
A
|
2016-12-20 00:00:00 UTC
|
Agilent to Buy Multiplicom for €68M in Cash
|
A
|
2016-12-06 00:00:00 UTC
|
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'
|
A
|
2016-11-16 00:00:00 UTC
|
The Market In 5 Minutes: DryShips, Trump And Target
|
A
|
2016-11-16 00:00:00 UTC
|
A Peek Into The Markets: U.S. Stock Futures Decline Ahead Of Economic Data
|
A
|
2016-11-16 00:00:00 UTC
|
Keep an Eye on These 8 Stocks for November 16, 2016
|
A
|
2016-11-15 00:00:00 UTC
|
Agilent Technologies Sees FY17 Rev. $4.35B-$4.37B vs. Est. $4.35B, EPS $2.10-$2.16 vs. Est. $2.19; Q4 Rev. $1.04-$1.04B vs. Est. $1.08B, EPS $0.48-$0.50 vs. Est. $0.53
|
A
|